RxDoctor Payments Data

Nathalie Cohenca

Physician Assistant · Kirkland, WANPI 1144894858

Payments from drug & device makers

$2,691in general payments, 2019–2025

Across 125 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$435
  • Bristol Myers Squibb$409
  • Takeda Pharmaceuticals U.S.A., Inc.$320
  • Madrigal Pharmaceuticals$263
  • Regeneron Healthcare Solutions, Inc.$218
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
  • plus $830 from 14 others

What the payments were for

  • Food & beverage$2,66199%
  • Education$301%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,691 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$30,622
Medicare patients
193
Services billed
247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide17$8,712
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates56$3,619
ClenpiqSod Picosulf/Mag Ox/Citric Ac21$3,616
Colestipol Hcl21$2,139
Omeprazole100$1,591
Peg3350-Sod Sul-Nacl-Kcl-Asb-CPeg3350/Sod Sul/Nacl/Kcl/Asb/C16$1,039
Pantoprazole Sodium68$964
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg25$570
Famotidine42$310
Ondansetron OdtOndansetron12$155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$435$8,71217 claims
Ferring Pharmaceuticals Inc.Clenpiq$14$3,61621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →